Press Releases

New fund will support rising scientists advancing innovation in breast cancer research SharkNinja, a global product design and technology company, today announced the We Won’t Wait Fund through a new partnership with the Breast Cancer Research Foundation (BCRF), committing a minimum of $250,000 to advance breast cancer research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001560284/en/ Launched in recognition of Breast Cancer Awareness Month, the SharkNinja We Won’t Wait Fund is rooted in a simple belief: the time to invest in innovative breast cancer research is now. The fund will support early-career researchers, helpi

KNOT Offshore Partners LP (NYSE:KNOP) ("The Partnership") Distribution for 3Q 2026 The Partnership announced today that its Board of Directors has declared a quarterly cash distribution with respect to the quarter ended September 30, 2026, of US$ 0.10 per common unit. This cash distribution will be paid on November 12, 2026, to all unitholders of record as of the close of business on October 26, 2026. This distribution reflects the Partnership’s belief, as outlined on May 28, 2026, that the combination of accretive dropdowns and improvements from rechartering should support multiple, gradual distribution increases over the coming quarters and years. About KNOT Offshore Partners LP

Receive a $10 Bonus Card for every $50 in Gift Cards Purchased Online October 1 through October 25 The Cheesecake Factory® (NASDAQ:CAKE), synonymous with delicious desserts, is celebrating the start of National Dessert Month with a special online gift card offer now through October 25: For every $50 in Gift Cards purchased online in a single transaction from Thursday, October 1 through Sunday, October 25, guests will receive a complimentary $10 Bonus Card redeemable October 26 through November 22, 2026*. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001374644/en/The Cheesecake Factory is sweetening National Dessert Month t

ENGLEWOOD, Colo., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) today announced sales of substantially all of the Section 45Z tax credits generated by its ethanol and renewable natural gas (RNG) facilities in 2026, totaling $70 million worth of credits. Gevo has received over $30 million in cash from these credit sales through September 30 and expects the remaining cash to be received over the next six months. The credits were generated through the production and sale of low-carbon transportation fuels and were sold by Gevo pursuant to the credit’s transferability provisions.  On September 30, Gevo sold $50 million worth of credits to a non-financial, publicly traded company.

Award recognizes Pathward’s commitment to helping fintechs and payments innovators bring new solutions to market and scale responsibly. Pathward Financial, Inc. (NASDAQ:CASH) through its subsidiary, Pathward®, N.A. ("Pathward"), today announced that Pathward has been named Partner Bank of the Year as part of The Big Bank Theory Awards 2026, presented by Tearsheet. The Big Bank Theory Awards is Tearsheet’s premier awards program recognizing and celebrating innovation in banking and embedded finance. The Partner Bank of the Year Award recognizes the best partner bank behind digital bank offerings. This press release features multimedia. View the full release here: https://www.businesswire.

More than half of employers are offering higher-than-planned salaries to attract new hiresSan Francisco, Denver and Seattle lead U.S. cities in employers offering higher-than-planned salariesMENLO PARK, Calif., Oct. 1, 2026 /PRNewswire/ -- Global talent solutions and business consulting firm Robert Half has released its 2027 Salary Guide, featuring projected salaries for hundreds of positions across 7 professional fields, along with compensation trends and hiring insights. The salary ranges reflect base salaries for new hires across all levels of experience. Experience the full interactive Multichannel News Release here: https://www.multivu.com/robert-half/9416751-en-robert-half-2027-salary-

PLYMOUTH MEETING, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced that it will present a poster featuring information from its ongoing Phase 3 trials of HBS-301, including ONSTRIDE-1 in narcolepsy and ONSTRIDE-2 in idiopathic hypersomnia. This poster will be presented at the 17th European Narcolepsy Days, taking place October 2–3, 2026, in Bern, Switzerland. Poster details are listed below: Abstract Title:Phase 3, randomized, double-blind, placebo-controlled studies of HBS-301 for narcolepsy and idiopathic hypersomniaDate/Times:October 2, 16:30 (CEST)October 3, 12:30 (CEST)   About HBS-301 HBS-301 is an investigational, optimized, hi

Peer-reviewed publication in Journal for ImmunoTherapy of Cancer reports median overall survival of 24.5 months in advanced non-small cell lung cancer (NSCLC) patients with inadequate response to immune checkpoint inhibitors (ICI) NEEDHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced the publication of final phase 2a clinical trial results (NCT04495153) of aglatimagene besadenovec (aglatimagene) plus valacyclovir in patients with stage III/IV NSCLC who had shown inadequ

NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- StepStone Group Inc. (NASDAQ:STEP), a leading global private markets investment firm, today announced that Yoshitaka Todoroki has joined the firm as a Vice Chairman, focusing on strategic initiatives in Japan and the broader Asia region. Mr. Todoroki joins StepStone following a distinguished career in private markets investing spanning more than 30 years. Most recently, he served as Executive Director of the Private Market Investment Department at Japan’s Government Pension Investment Fund (GPIF). Throughout his decade-long tenure at GPIF, Mr. Todoroki led the development of the pension fund’s private markets investment program across private eq

LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its third quarter 2026 financial results on Friday, October 30, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company’s investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference c

Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis (NCT06207370) to be disclosed on October 6, 2026.Key Opinion Leader investor webinar scheduled for October 6, 2026, featuring leading babesiosis experts Dr. Peter Krause and Dr. Edouard Vannier. WASHINGTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW)) ("60 Degrees" or the "Company"), a pharmaceutical company that develops and commercializes new medicines for vector-borne disease, today announced that it will disclose the outcome of the interim analysis from its clinical study evaluating tafenoquine in patients hospitalized with severe babesiosis (NCT06207370

McKesson Corporation (NYSE:MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies, and distribution centers through June 2032. "We are pleased to extend our long-standing, strategic relationship with CVS Health and continue supporting their important role in serving patients and communities across the country," said Brian Tyler, chair and chief executive officer of McKesson. "For more than 25 years, our teams have worked together to deliver reliable, high-quality services to patients, and we remain committed to building on that strong foundation thro

SARASOTA, Fla., Oct. 1, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics, Inc. (NASDAQ:LABT, the ", Company", )), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class, today announced that CEO Kelvin Cooper, Ph.D., will participate in three upcoming industry conferences.Dr. Cooper is scheduled to attend the Maxim Growth Summit on October 14, 2026, in New York City. He will also attend and present at the ThinkEquity Conference on October 15, 2026, in New York City. Later in the month, Dr. Cooper will present a poster on Nu-3 preclinical data at IDWeek on October 22, 2026

REDWOOD CITY, Calif., Oct. 1, 2026 /PRNewswire/ -- Equinix, Inc. (NASDAQ:EQIX), the world's digital infrastructure company®, today announced that it will hold its quarterly conference call on Wednesday, October 28, 2026, at 5:30 p.m. ET (2:30 p.m. PT). The company will discuss third-quarter results for the period ended September 30, 2026.To hear the conference call live, please dial 1-517-308-9482 (domestic and international) and reference the passcode: EQIX. A simultaneous live webcast of the call will be available on the Investor Relations site. A replay of the call will be available one hour after the call through Thursday, December 31, 2026, by dialing 1-800-814-6745 and entering the pas

Investment reinforces Kyndryl's commitment to advancing customer innovation and AI adoption across the United StatesNEW YORK, Oct. 1, 2026 /PRNewswire/ -- Kyndryl (NYSE:KD), a leading provider of mission-critical enterprise technology services, today announced the opening of its first U.S. AI Innovation Lab in the Dallas-Fort Worth area. The investment is expected to create up to 300 highly skilled jobs in AI, technology consulting and design engineering over the next four years. The Lab also reinforces Kyndryl's long-term commitment to America's digital future and to advancing innovation, workforce development and customer engagement in the U.S."The future of AI will be built through collab

RESTON, Va., Oct. 1, 2026 /PRNewswire/ -- Leidos (NYSE:LDOS) is welcoming Jeff McElfresh, AT&T's chief operating officer, to its board of directors effective October 1. His joining the Leidos board represents the addition of another excellent leader with success developing and deploying advanced technologies at scale in commercial and public sector markets.   McElfresh's AT&T (NYSE:T) career spans more than 30 years. Currently he oversees AT&T's $250 billion nationwide advanced connectivity infrastructure transformation, an expertise that aligns well with Leidos' core digital work and expanding energy infrastructure business. Also very relevant to Leidos, in prior roles he oversaw AT&T's cyb

Armada II shareholders approved the business combination with Evernorth at the extraordinary general meeting on September 30, 2026Transaction expected to raise approximately $300 million in gross cash proceedsInvestors have also contributed XRP in kind; at closing, Evernorth expected to become the largest publicly traded pure-play XRP treasury company, with approximately 473 million XRPInvestor support for transaction unwavering; 100% of advanced and delayed funders participatingBusiness combination expected to close October 7, 2026, with trading on Nasdaq under the ticker "XRPN" expected to begin October 8, 2026SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Evernorth Holdings, Inc. ("Evernorth

BRANFORD, Conn., Oct. 1, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE:AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the completion of Cohort 1 in its Phase 1/2 clinical trial evaluating ATR04-484 as a potential treatment for EGFR inhibitor (EGFRi)-associated skin rash. Following its review of available safety data from patients enrolled in Cohort 1, the study's safety review committee recommended that the trial may proceed to Cohort 2, enabling Azitra to begin enrollment and dosing in the second cohort.The multicenter, randomized, double-blind, vehicle-controlled Phase 1/2 clinica

New platform marks TEN Holdings' evolution beyond virtual events toward a broader technology ecosystem connecting how organizations create, produce, engage, market and measure digital experiences.LANGHORNE, Pa., Oct. 1, 2026 /PRNewswire/ -- TEN Holdings, Inc. (NASDAQ:XHLD) ("TEN Holdings" or the "Company") today announced the launch of TEN, its new Digital Experience Platform and the technology foundation for the Company's long-term growth strategy.TEN brings together technology for creating, producing, engaging, marketing and measuring digital experiences within a single platform. The initial release includes a comprehensive suite of capabilities for enterprise events, webinars and continui

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) will announce its third quarter and nine month 2026 financial results in a press release to be issued Thursday morning, October 22, 2026. The press release will be available in the News & Announcements section of Lazard's website at www.lazard.com.Lazard will host a conference call at 8:00 a.m. ET on October 22, 2026, to discuss the company's financial results. The conference call can be accessed via a live audio webcast available through the Investor Relations section of Lazard's website at www.lazard.com, or by dialing 1 800-445-7795 (toll-free within the U.S. and Canada) or +1 785-424-1699 (outside of the U.S. and Canada) 15 m